These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 561163)

  • 21. The amantadine-sensitivity of recombinant and parental influenza virus strains.
    Hamzawi M; Jennings R; Potter CW
    Med Microbiol Immunol; 1981; 169(4):259-68. PubMed ID: 7278806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
    Oxford JS
    J Antimicrob Chemother; 1975 Mar; 1(1):7-23. PubMed ID: 1100585
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiviral activity of amantadine: a review of laboratory and clinical data.
    Oxford JS; Galbraith A
    Pharmacol Ther; 1980; 11(1):181-262. PubMed ID: 6159656
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo selection of an influenza A2 strain resistant to amantadine.
    Oxford JS; Logan IS; Potter CW
    Nature; 1970 Apr; 226(5240):82-3. PubMed ID: 5434369
    [No Abstract]   [Full Text] [Related]  

  • 25. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Search for a synergism with different drugs in the field of antiviral chemotherapy.
    Altucci P; Degen L; Del Vecchio-Blanco C; Varone GL; Magrassi F
    Chemotherapy; 1971; 16(4):259-68. PubMed ID: 5121719
    [No Abstract]   [Full Text] [Related]  

  • 27. Electron microscopic observations on the entry of influenza virus into susceptible cells.
    Dourmashkin RR; Tyrrell DA
    J Gen Virol; 1974 Jul; 24(1):129-41. PubMed ID: 4367305
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitivity of influenza A/New Jersey/8/76 (Hsw1N1) virus to amantadine-HCl.
    Grunert RR; Hoffmann CE
    J Infect Dis; 1977 Aug; 136(2):297-300. PubMed ID: 894080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual effect in the mechanism of action of anti-influenza virus amino acid analogues.
    Fujita H
    Antimicrob Agents Chemother; 1973 Jan; 3(1):57-62. PubMed ID: 4790576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.
    Abed Y; Goyette N; Boivin G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):556-9. PubMed ID: 15673732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine.
    Lavrov SV; Eremkina EI; Orlova TG; Galegov GA; Soloviev VD; Zhdanov VM
    Nature; 1968 Mar; 217(5131):856-7. PubMed ID: 5641149
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular basis of resistance of influenza A viruses to amantadine.
    Hay AJ; Zambon MC; Wolstenholme AJ; Skehel JJ; Smith MH
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():19-29. PubMed ID: 3793659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
    Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza virus strains with a fusion threshold of pH 5.5 or lower are inhibited by amantadine. Brief report.
    Beyer WE; Ruigrok RW; van Driel H; Masurel N
    Arch Virol; 1986; 90(1-2):173-81. PubMed ID: 3089198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic interaction between two influenza A-WS virus mutants. II. Genetic interaction between NWS-D and WS-MK viruses in human diploid cells and hamster embryo fibroblasts.
    Kutinová L; Tucková E; Vonka V; Stárek M
    Acta Virol; 1971 Sep; 15(5):345-51. PubMed ID: 4399132
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
    Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
    J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The dynamics of multiplication of influenza-virus A-2 in mouse lungs under the influence of 1-aminoadamantan preparations].
    Benda R; Rehn F; Dostálová J
    Zentralbl Bakteriol Orig; 1969 Jul; 210(3):298-303. PubMed ID: 5358861
    [No Abstract]   [Full Text] [Related]  

  • 39. [A screening method for anti-influenzal drugs; influenza virus propagation inhibition test (author's transl)].
    Tao SJ
    Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):359-61. PubMed ID: 6796238
    [No Abstract]   [Full Text] [Related]  

  • 40. Excess amantadine use and resistant viruses.
    Suzuki H; Saito R; Oshitani H
    Lancet; 2001 Dec; 358(9296):1910. PubMed ID: 11741673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.